After A 50% Decline, Coloplast Might Finally Be Worth Buying

2025-10-29 05:40:01 ET

At the end of March 2025, I published my last article about Coloplast A/S ( CLPBF ), and in the article I argued that the stock was cheaper than in previous years as Coloplast is now in a multi-year corrective pattern, but I also argued that Coloplast was still not a bargain, and in the conclusion of my last article, I wrote:

Coloplast is now more reasonably valued than it was in the last few years. However, Coloplast is neither cheap at this point (still trading for high valuation multiples) and the chart is also indicating that the stock might decline lower.

When investing in Coloplast at this point, I assume that we can achieve a high-single digit return on investment over the long run, and we also get a 3% dividend yield. And although Coloplast is a great business with a wide economic moat, I still think there are better investments in this market. Coloplast will likely need to decline further – perhaps another 20% - before it becomes a truly attractive investment.”

Read the full article on Seeking Alpha

For further details see: